Qmenta Care Platform Family

by QMENTA  · Based in United States →The all-in-one imaging platform for your clinical trials, research, and care providers.
Neurology Nuclear Medicine Radiology

By quote/rfp
Regulatory Status Disclosed

Overview

QMENTA Care Platform Family, developed by QMENTA (formerly Mint Labs, Inc.), is a cloud-based medical imaging system designed for comprehensive neuroimaging data management, processing, and analysis. It enables healthcare providers, researchers, and pharmaceutical companies to manage DICOM images and textual reports, organize and store them, and make this information accessible across a network via web and customized user interfaces. The platform integrates AI-powered tools and biomarkers to provide quantitative insights into brain features and changes, aiding in neurology evaluation, diagnosis, and treatment decision-making. It supports multi-modal data including MRI, PET, CT, OCT, and EEG, and offers automated de-identification of Protected Health Information (PHI) to ensure patient privacy.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Smart Uploader with auto PHI de-identification and image quality checks
  • Imaging Cloud with secure PACS connection and automated workflows
  • AI Imaging Biomarkers (50+ algorithms available, with API for custom integration)
  • Central Review with adjudication tools
  • Imaging Management System with imaging EDC, query management, and reporting
  • Multi-modal imaging data management (MRI, PET, CT, OCT, EEG)
  • Automated, visual patient reports (exportable PDF)
  • Cloud-based platform for data aggregation and analysis
  • Configurable dataflow management
  • Integrated de-identification within firewall

Use Cases

  • Clinical trials management (imaging-centric)
  • Neuroscience research (academics, research institutions)
  • Clinical care and diagnosis support (diagnostic centers, outpatient networks)
  • Therapeutics development (biopharma, CROs, medical devices)
  • Diagnostic development (AI digital biomarkers, med-tech innovators)
  • Legal practices for medical imaging review

What Physicians Need to Know

Stroke Detection Speed
The Qmenta Care Platform Family aims to enable diagnostic speed and rapid, accurate detection of stroke. Through a partnership with Quantib, the platform integrates a stroke decision support tool that automatically identifies ischemic or hemorrhagic stroke on non-contrast CT scans.
Brain MRI/CT Analysis
The platform provides tools for managing multi-modal data, including MRI and CT. It offers over 50 cutting-edge AI imaging biomarkers and algorithms for quantifiable analysis of scans, visualizing features and changes in the brain, and assisting with disease onset and progression assessment, diagnosis, and prognosis.
Seizure Detection
Specific AI-driven seizure detection capabilities within the Qmenta Care Platform Family were not explicitly detailed in the provided search results. The platform primarily focuses on imaging biomarkers for neurological diseases.
Neurodegenerative Disease Screening
Qmenta's platform is designed to advance research and improve diagnosis and prognosis for neurodegenerative disorders such as Alzheimer's, Multiple Sclerosis, and Parkinson's disease. It leverages advanced neuroimaging techniques and AI biomarker tools for early detection and tracking disease progression.
Large Vessel Occlusion Detection
While not explicitly stated as a direct Qmenta feature, the platform's partnership with Quantib for stroke decision support includes capabilities to identify different types of stroke on CT scans, which is crucial for conditions like large vessel occlusion. AI-enabled triage tools, which Qmenta integrates, can automatically analyze CT angiography images to detect large vessel occlusions.
Triage Prioritization Speed
The Qmenta platform aims to streamline workflows and enable diagnostic speed, which contributes to faster decision-making. AI-enabled platforms like Qmenta can integrate with imaging triage systems to optimize workflow and individual management by prioritizing imaging requests.
ASPECTS Score Automation
Through integrations, the Qmenta platform can support tools like the Stroke CT Alberta Stroke Program Early CT Score (CINAu00ae ASPECTS) application, which utilizes deep learning algorithms to help identify and locate areas of potential ischemia and provides an ASPECT score within a non-contrast CT imaging series.
Mobile Notification System
While the Qmenta platform supports web and customized user interfaces, specific details about a dedicated mobile notification system for alerts or results were not explicitly found in the provided information. The platform is cloud-based and accessible via a web browser.
Physician Tip

Physicians can leverage the Qmenta Care Platform Family to manage imaging data, apply AI biomarker tools for quantified insights into brain features and changes, and generate comprehensive visual reports for faster care decisions. The platform helps overcome challenges in manual analysis, aids in treatment decision-making by providing objective data, and improves diagnosis and prognosis confidence. It offers access to a catalog of over 50 AI algorithms and biomarker tools, assisting with quantification and analysis of disease onset and progression. The system is designed to reduce variability, time, cost, and error in neurological evaluations.

The Qmenta Care Platform Family is designed for extensive integration. It enables aggregation and integration with medical image Picture Archiving and Communications (PACS) tools, reducing variability and error. The platform hosts a Medical Imaging AI Analyses Catalog with over 50 marketed and research-only AI algorithms from scientific leaders. It also provides a Software Development Kit (SDK) to integrate legally marketed third-party applications, allowing AI innovators to port novel AI models and enabling partnerships with companies like Imaging Biometrics and Quantib for specialized tools and solutions.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing By quote/rfp
  • No public tiered pricing; QMENTA Starter Kit: 2-month trial with up to $30,000 in free QMENTA Cloud credits
DeploymentCloud (SaaS/PaaS)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

QMENTA Care Platform Family received FDA 510(k) clearance (K202718) on June 16, 2021, as a Class II medical device (product code LLZ). It is a software medical imaging system intended to receive DICOM images and textual reports, organize and store them, and make this information available across a network via web and customized user interfaces, aiding suitably qualified physicians in neurology evaluation and improving diagnosis confidence and accuracy.

Integrations
EHR Not specified
Specialties Neurology, Nuclear Medicine, Radiology

What the Web Says

QMENTA Care Platform Family is an AI-powered, cloud-based platform designed for neuroimaging and clinical trial management, particularly in neurology. It aims to streamline workflows, manage imaging data, and provide quantitative analysis using advanced AI algorithms for research, clinical trials, and point-of-care. The platform has received FDA 510(k) clearance, making it suitable for use by qualified healthcare providers to enhance neurology evaluation and improve diagnostic confidence and accuracy.

Overall: Positive

Strengths

  • Globally accessible, infinitely scalable, and AI-powered collaborative cloud platform.
  • Purpose-built by neuroimaging and data science experts to meet the distinct needs of the neuroscience community.
  • Streamlined, end-to-end clinical, real-world data, and medical imaging data management.
  • Offers a comprehensive set of over 50 marketed and research-only AI algorithms for imaging analysis and reporting.
  • FDA 510(k) cleared and compliant with industry regulations including HIPAA, GDPR, and ISO 13485.
  • Reduces reading time and total costs for clinical trials.

Limitations

  • Limited reviews available on platforms like G2 and Capterra, making it difficult to gather widespread user opinions.
  • The cloud-based solution may require setting up specific ports and authorization, which can involve paperwork.
  • Lack of integration with existing Electronic Medical Records (EMRs) was noted as a limitation for a similar digital health platform, which could potentially apply to QMENTA depending on specific integrations.
  • No reviewer feedback on customer support quality is available from some catalog data.
  • Primarily focused on neuroimaging, which might limit its applicability for other medical specialties compared to more general platforms.

Based on reviews from: SourceForge, G2, Trustpilot, SoftwareWorld, QMENTA.com, DOTmed, AuntMinnie, Reddit, Capterra, Neurofounders

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Qmenta Care Platform Family

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

QMENTA
Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021
QMENTA announced FDA 510(k) clearance for its QMENTA Platform for Care in November 2021, enabling healthcare providers to use the platform for neurology evaluation and improved diagnosis. The platform is designed to manage imaging data and apply AI-enabled tools for quantified insights into brain features and changes.
2021-11
FDA
K202718 - 510(k) Premarket Notification
This FDA document details the 510(k) premarket notification for the Qmenta Care Platform Family (formerly The QMENTA Care Family Platform), submitted by Mint Labs, Inc., d/b/a Qmenta. The clearance was granted on June 16, 2021, classifying it as a Class II Medical Device for radiological image processing.
2021-06
Stevie Awards
QMENTA - Female Entrepreneur of the Year
This article highlights Dr. Vesna Prchkovska's achievements as CEO of QMENTA, including securing FDA 510(k) clearance for the QMENTA Care Platform Family in July 2021. QMENTA's AI-powered cloud platform aims to transform brain disease understanding and treatment by streamlining data aggregation, compliance, collaboration, and analysis.
2021-09
Evercare.ru
FDA u043eu043fu0443u0431u043bu0438u043au043eu0432u0430u043bu0430 u0441u043fu0438u0441u043eu043a u0441u0435u0440u0442u0438u0444u0438u0446u0438u0440u043eu0432u0430u043du043du044bu0445 u0441u0438u0441u0442u0435u043c (u0443u0441u0442u0440u043eu0439u0441u0442u0432) u043du0430 u0431u0430u0437u0435 u0438u0441u043au0443u0441u0441u0442u0432u0435u043du043du043eu0433u043e u0438u043du0442u0435u043bu043bu0435u043au0442u0430 u0438 u043cu0430u0448u0438u043du043du043eu0433u043e u043eu0431u0443u0447u0435u043du0438u044f
This Russian article from Evercare.ru lists FDA-certified AI and machine learning-based systems and devices, including the Qmenta Care Platform Family with clearance date 06/16/2021.
2021-09
Scribd
Artificial Intelligence and Machine Learning (AIML) - Enabled Medical Devices FDA
This document from Scribd provides a list of FDA-enabled medical devices utilizing Artificial Intelligence and Machine Learning, featuring the Qmenta Care Platform Family.
unknown
AuntMinnie.com
CT/CTA workflow radiology AI tools | Buyer shortlist
The Qmenta Care Platform Family is listed as an image analysis/processing tool for CT/CTA modality in this buyer's shortlist of radiology AI tools.
unknown
DOKUMEN.PUB
Concepts of Artificial Intelligence and its Application in Modern Healthcare Systems
This publication discusses the application of AI in healthcare, mentioning the Qmenta Care Platform Family (K202718) as an example of an AI-enabled medical device cleared by the FDA on June 16, 2021.
2024
Innolitics
LLZ u00b7 System, Image Processing, Radiological u2014 FDA Product Code
Innolitics lists the Qmenta Care Platform Family under the FDA product code LLZ (System, Image Processing, Radiological), indicating its clearance as a traditional device on June 16, 2021.
2021-06

Videos

Product demos, reviews, and walkthroughs for Qmenta Care Platform Family.

View all on YouTube

Frequently Asked Questions

The Qmenta Care Platform Family is an FDA 510(k) cleared, AI-powered cloud-based platform designed to enhance neurology evaluations and improve diagnosis confidence and accuracy. It provides access to a catalog of over 50 AI algorithms and biomarker tools for quantifying and analyzing disease onset, progression, diagnosis, and prognosis, particularly in neurological conditions. Physicians can use these tools to manage imaging data, visualize, and gain quantified insights into brain features and changes, supported by comprehensive visual reports.
The Qmenta Care Platform Family is fully compliant with stringent industry regulations, including ISO 13485:2016, FDA 21 CFR Part 820 & 11, GDPR, and HIPAA. It has received FDA 510(k) clearance as a Class II Medical Device, affirming its safety and effectiveness for clinical use. The platform also incorporates features like automated Protected Health Information (PHI) de-identification and robust security measures within its cloud infrastructure to safeguard patient data.
The Qmenta Care Platform Family is primarily specialized for neuroimaging, meaning practices with broader radiology needs might find its scope limited for non-neuro imaging applications. Additionally, as a cloud-based solution, initial setup may involve administrative tasks related to configuring specific network ports and obtaining necessary authorizations.
The Qmenta Care Platform Family distinguishes itself with a strong focus on AI-powered neuroimaging and quantitative biomarkers, particularly beneficial for imaging-centric studies in neurology, oncology, and rare diseases. While alternatives like Medidata Rave Imaging offer broader eClinical platforms, Qmenta provides deeper, specialized imaging capabilities. Other competitors include general PACS solutions and various clinical trial management systems.
Qmenta does not publicly publish tiered pricing on its official website; pricing is typically provided by quote or through an RFP process. For those interested in evaluating the platform, a 'Qmenta Starter Kit' is advertised, offering a two-month trial with up to $30,000 in free Qmenta Cloud credits.
Yes, the Qmenta Care Platform Family is designed to be adaptable, allowing physicians to integrate their own AI algorithms and third-party tools. The platform provides an optimal environment for connecting, training, and validating custom AI biomarkers. It also offers an extensive marketplace with over 50 cutting-edge imaging biomarkers, including widely used open-source algorithms.
Qmenta ensures patient data security and privacy through a robust framework that includes hosting on a compliant cloud infrastructure with segregated networks and active firewalls. All data transfers are encrypted via HTTPS, and access is restricted to authenticated users with strict access controls and audit trails. Furthermore, Qmenta provides functionality to automatically strip Protected Health Information (PHI) from datasets and enters into Business Associate Agreements (BAAs) with clients and cloud providers.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18

Investors who backed Qmenta Care Platform Family

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.